Shares of EnQuest PLC (LON:ENQ - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 12.71 ($0.17) and traded as high as GBX 13.26 ($0.18). EnQuest shares last traded at GBX 12.80 ($0.17), with a volume of 2,239,778 shares trading hands.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group reiterated a "buy" rating on shares of EnQuest in a research report on Monday, March 31st.
Check Out Our Latest Stock Report on EnQuest
EnQuest Stock Up 2.0%
The company has a debt-to-equity ratio of 208.00, a current ratio of 0.76 and a quick ratio of 0.75. The company's 50-day simple moving average is GBX 12.50 and its 200 day simple moving average is GBX 12.75. The firm has a market cap of £307.09 million, a P/E ratio of 15.17, a price-to-earnings-growth ratio of 0.07 and a beta of 1.43.
EnQuest Company Profile
(
Get Free Report)
EnQuest is providing creative solutions through the energy transition.
EnQuest is an independent energy company. We focus on mature late-life assets, responsibly optimising production to provide energy security. Where we can, we repurpose our infrastructure to deliver renewable energy and decarbonisation projects before executing world-class decommissioning.
Featured Articles
Before you consider EnQuest, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EnQuest wasn't on the list.
While EnQuest currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
